JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Precision Oncology: Circulating Microvesicles as New Biomarkers in a Very Early Stage of Colorectal Cancer

  • 0Laboratory of Reliability and Quality Control in Laboratory Hematology (HemQcR), Department of Biomedical Sciences, School of Health & Caring Sciences, University of West Attica (UniWA), 12243 Egaleo, Greece.
Cancers +

|

May 25, 2024

|

May 25, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Circulating microvesicles (MVs) are elevated in colorectal cancer patients, even in early stages. Measuring these MVs may offer a new tool for early colon cancer diagnosis and understanding disease progression.

Area Of Science

  • Cell biology
  • Oncology
  • Biomarkers

Background

  • Microvesicles (MVs) mediate intercellular signaling in health and disease.
  • MVs play a multidimensional role in cancer, influencing survival, proliferation, and invasion.
  • This study investigates MV levels in colorectal cancer (CRC) patients.

Purpose Of The Study

  • To analyze circulating microvesicle levels in colorectal cancer patients.
  • To assess the significance of MV release in early-stage CRC and patient survival.

Main Methods

  • Prospective study involving 98 colorectal cancer patients and 15 controls.
  • Plasma microvesicles were characterized using flow cytometry and specific monoclonal antibodies.
  • Analysis included total MVs, MUC-1-positive MVs, tissue factor (TF)-positive MVs, and endothelial cell-derived MVs (EMVs).

Main Results

  • Colorectal cancer patients exhibited significantly higher levels of total MVs, MUC-1-positive MVs, TF-positive MVs, and EMVs compared to controls (p < 0.001).
  • Elevated MV levels were also observed in patients with very early-stage colorectal cancer (p < 0.01).
  • Highly differentiated tumors showed lower levels of MUC-1-positive MVs, EMVs, and EMV/TF combinations compared to less differentiated tumors (p < 0.02).

Conclusions

  • Circulating microvesicle analysis shows potential as a diagnostic tool for early-stage colon cancer detection.
  • Specific MV subtypes correlate with tumor differentiation, suggesting roles in cancer progression.
  • Further research could establish plasma MV analysis for non-invasive early diagnosis of colorectal cancer.

Keywords: